<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathophysiology of the trigeminal autonomic cephalalgias</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathophysiology of the trigeminal autonomic cephalalgias</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathophysiology of the trigeminal autonomic cephalalgias</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Arne May, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna S Cohen, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Goadsby, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jerry W Swanson, MD, MHPE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The trigeminal autonomic cephalalgias are a group of primary headache disorders characterized by unilateral trigeminal distribution pain that occurs in association with prominent ipsilateral cranial autonomic features [<a href="#rid1">1,2</a>]. The trigeminal autonomic cephalalgias include cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), and hemicrania continua [<a href="#rid3">3</a>].</p><p>This topic will review the pathophysiology of the trigeminal autonomic cephalalgias. </p><p>Clinical aspects of these disorders are discussed separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">"Cluster headache: Epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3351.html" rel="external">"Cluster headache: Treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3334.html" rel="external">"Paroxysmal hemicrania: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3335.html" rel="external">"Paroxysmal hemicrania: Treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3336.html" rel="external">"Short-lasting unilateral neuralgiform headache attacks: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3338.html" rel="external">"Short-lasting unilateral neuralgiform headache attacks: Treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3342.html" rel="external">"Hemicrania continua"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGIC MODELS</span><span class="headingEndMark"> — </span>The pathogenesis of the trigeminal autonomic cephalalgias – cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), and hemicrania continua – is complex and remains incompletely understood. Any pathophysiologic construct for trigeminal autonomic cephalalgias must account for the three major features that are common to the syndromes:</p><p class="bulletIndent1"><span class="glyph">●</span>Trigeminal distribution pain</p><p class="bulletIndent1"><span class="glyph">●</span>Ipsilateral cranial autonomic features</p><p class="bulletIndent1"><span class="glyph">●</span>Cyclical variation of attacks</p><p></p><p>In addition, the underlying pathophysiology should account for the differentiation of the syndromes, including the episodic (cyclical) pattern of attacks seen in cluster headache [<a href="#rid4">4</a>].</p><p>The excruciatingly severe unilateral pain is likely to be mediated by activation of the first (ophthalmic or V1) division of the trigeminal nerve, while the autonomic symptoms, such as lacrimation, are due to activation of the cranial parasympathetic outflow from cranial nerve VII [<a href="#rid5">5</a>]. The sympathetic paralysis (miosis and ptosis) may be caused by a (neurapraxic) injury of postganglionic fibers in most patients [<a href="#rid6">6,7</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Trigeminal autonomic reflex</span><span class="headingEndMark"> — </span>The trigeminal autonomic reflex encapsulates the notion that stimulation of trigeminal afferents can result in cranial autonomic outflow.</p><p class="bulletIndent1"><span class="glyph">●</span>The pain-producing innervation of the cranium projects through branches of the trigeminal and upper cervical nerves to the trigeminocervical complex in the caudal brainstem and upper cervical spinal cord. From there, nociceptive pathways project to higher centers. This reflex may be supported by a direct peripheral connection between the sphenopalatine ganglion (SPG) and trigeminal ganglion [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The ipsilateral autonomic features of the trigeminal autonomic cephalalgias suggest cranial parasympathetic activation (lacrimation, rhinorrhea, nasal congestion, and eyelid edema) and sympathetic hypofunction (ptosis and miosis). These cranial autonomic symptoms are thought to result, in part, from activation of the trigeminal autonomic reflex [<a href="#rid1">1,9,10</a>]. </p><p></p><p>There is considerable experimental animal literature showing that stimulation of trigeminal afferents can result in cranial autonomic outflow [<a href="#rid9">9</a>]. Some degree of cranial autonomic symptomatology is a normal physiologic response to cranial nociceptive input [<a href="#rid11">11,12</a>]. In addition, electrical stimulation in the brainstem at the level of the superior salivatory nucleus, which is the origin of cells for the cranial parasympathetic autonomic vasodilator pathway, results in both neuronal trigeminovascular and cranial autonomic responses [<a href="#rid10">10</a>]. </p><p>The SPG is an extracranial parasympathetic ganglion located in the pterygopalatine fossa that may be a potential treatment target. Post-ganglionic parasympathetic fibers from the SPG innervate facial structures and the cerebral and meningeal blood vessels; they also mediate the trigeminal-autonomic reflex. The theoretical construct is that high frequency stimulation leads to a depolarization within the ganglion, which effectively blocks the peripheral parasympathetic innervation of the eye and nose [<a href="#rid13">13</a>]. In clinical trials, SPG stimulation relieved pain of cluster headache attacks in approximately two-thirds of patients [<a href="#rid13">13,14</a>].</p><p>Painful activation of the trigeminovascular system leads to neuropeptide release. In patients with cluster headache, alterations have been found in the levels of calcitonin gene-related peptide (CGRP), pituitary adenylate cyclase-activating peptide (PACAP), and nitric oxide synthase [<a href="#rid15">15</a>]. Monoclonal antibodies against CGRP may be useful for episodic and chronic cluster headache [<a href="#rid16">16-18</a>]. </p><p>Cranial autonomic symptoms are also recognized in other forms of head pain, including experimental head pain with <a class="drug drug_general" data-topicid="8840" href="/z/d/drug information/8840.html" rel="external">capsaicin</a> injection [<a href="#rid19">19</a>] and other headache syndromes such as migraine [<a href="#rid20">20,21</a>]. The main distinction between the trigeminal autonomic cephalalgias and other headache syndromes is, next to the shortness of attacks, the degree of cranial autonomic activation and its often prominent lateralization [<a href="#rid22">22,23</a>]. The cranial autonomic symptoms may be prominent in the trigeminal autonomic cephalalgias due to a central disinhibition of the trigeminal-autonomic reflex.</p><p>In chronic cluster headache, the headache and autonomic symptoms may be generated entirely through central mechanisms, as an activation of the trigeminal autonomic reflex is not necessary (any more) to display the full clinical picture [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Hypothalamic activation</span><span class="headingEndMark"> — </span>The posterior hypothalamic region plays an important role in the pathophysiology of the trigeminal autonomic cephalalgias [<a href="#rid25">25</a>]. Several characteristic cluster headache features imply involvement of a biologic clock in the origin of the illness, namely the suprachiasmatic nucleus of the hypothalamus [<a href="#rid26">26-28</a>]. These include the relapsing-remitting course [<a href="#rid29">29</a>], seasonal variation [<a href="#rid29">29,30</a>], and the clockwise regularity of single attacks [<a href="#rid31">31</a>].</p><p>Hypothalamic involvement is suggested by lowered levels of plasma testosterone in some males with cluster headache during bouts [<a href="#rid32">32</a>]. Further support was provided by the finding of a reduced response to thyrotropin-releasing hormone [<a href="#rid33">33</a>] and by a range of other circadian irregularities in patients with cluster headache. As an example, melatonin is a marker of the circadian system, and one study found that patients with cluster headache during cluster periods demonstrated a blunted nocturnal peak in melatonin level and a complete loss of a circadian rhythm [<a href="#rid34">34</a>].</p><p>The following observations from experimental animal and clinical neuroimaging studies also support the role of the hypothalamus in pain modulation:</p><p class="bulletIndent1"><span class="glyph">●</span>There are direct hypothalamic-trigeminal connections [<a href="#rid35">35,36</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The hypothalamus is involved in anti-nociceptive and autonomic responses [<a href="#rid37">37-39</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The hypothalamus is activated during acute cluster headache when intracranial pain structures are activated [<a href="#rid40">40</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The hypothalamic neuropeptides orexin A and B can elicit pro-nociceptive and anti-nociceptive effects in the trigeminal system [<a href="#rid41">41</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Activation of the trigeminal-autonomic reflex by a painful stimulus causes activation of the anterior hypothalamus, locus coeruleus, and ventral posterior medial nucleus of the thalamus [<a href="#rid42">42</a>]</p><p></p><p class="headingAnchor" id="H1424292096"><span class="h3">Anatomic correlates</span><span class="headingEndMark"> — </span>Functional imaging data suggest that primary headache syndromes can be distinguished on a neuroanatomic basis by areas of activation specific to the clinical presentation [<a href="#rid43">43-45</a>]. Positron emission tomography (PET) studies in cluster headache [<a href="#rid46">46,47</a>], paroxysmal hemicrania [<a href="#rid48">48</a>], and hemicrania continua [<a href="#rid49">49</a>] and functional magnetic resonance imaging studies in SUNCT syndrome [<a href="#rid50">50-52</a>] have demonstrated that all of these headache syndromes share an activation of the region of the posterior hypothalamic gray. Other studies using deep brain stimulation refer to this region as the midbrain tegmentum [<a href="#rid53">53</a>]. The terminology is interchangeable and the distinction unimportant without human anatomical data.</p><p>For hemicrania continua, which shares some symptoms of migraine and cluster headache, PET imaging has shown significantly increased activity in the posterior hypothalamus (involved with trigeminal autonomic cephalalgias generation), in the dorsal rostral pons, and the ipsilateral ventrolateral midbrain (involved with migraine generation) [<a href="#rid49">49</a>]. This activity may be successfully blocked with <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">indomethacin</a>. In addition, hypothalamic activation does not accompany experimental trigeminal distribution head pain [<a href="#rid54">54,55</a>]. These findings have led to the successful introduction of a therapeutic target for cluster headache and the other trigeminal autonomic cephalalgias using deep brain stimulation of the posterior hypothalamic gray matter [<a href="#rid25">25</a>].</p><p>Of note, anatomically distinct regions of the hypothalamus have been implicated in migraine attack generation [<a href="#rid56">56-58</a>]. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Pathophysiology'</a>.)</p><p class="headingAnchor" id="H474800465"><span class="h3">Temporal correlates</span><span class="headingEndMark"> — </span>The hypothalamic involvement in the pain process appears to occur in a phase-dependent permissive or triggering manner rather than simply as a response to pain mediated by the trigeminal nociceptive pathways [<a href="#rid9">9,59</a>]. Compared with healthy controls, patients with cluster headache exhibited functional connectivity changes between the hypothalamus and medial frontal gyrus and occipital cuneus [<a href="#rid60">60</a>]. Moreover, changes were observed in functional connectivity in the medial frontal gyrus, precuneus, and cerebellum, and in dorsal and frontal attention networks between in-bout and out-of-bout status [<a href="#rid13">13</a>]. More work in this area is needed.</p><p>In contrast with hypothalamic activation in trigeminal autonomic cephalalgias, most studies in episodic and chronic migraine attacks have not observed ictal hypothalamic activation [<a href="#rid61">61-65</a>], although there are exceptions [<a href="#rid66">66</a>]. Hypothalamic involvement in migraine appears to occur shortly before but not during the attack [<a href="#rid56">56,57,67</a>].</p><p class="headingAnchor" id="H1742683737"><span class="h2">Vascular theory</span><span class="headingEndMark"> — </span>The vascular theory holds that the clinical symptoms of cluster headache are caused by neurogenic inflammation of the walls of the cavernous sinus, which is the only peripheral anatomic location where a single pathology could involve trigeminal C-fibers and sympathetic fibers [<a href="#rid68">68</a>]. This inflammation is postulated to obliterate venous outflow and thus injure the traversing sympathetic fibers of the intracranial internal carotid artery and its branches [<a href="#rid19">19,68</a>], thus explaining the unilateral pain and ipsilateral damage of sympathetic outflow.</p><p>The vascular theory has been largely abandoned by the recognition that the neurovascular phenomena related to the trigeminal autonomic reflex and some central impulse generator or "oscillator" – thought to be in the hypothalamic region – seem to be more important.</p><p class="headingAnchor" id="H7"><span class="h1">OUTSTANDING ISSUES</span><span class="headingEndMark"> — </span>There are several issues that remain unresolved in the understanding of the pathophysiology of the trigeminal autonomic cephalalgias.</p><p class="bulletIndent1"><span class="glyph">●</span>What is the nature of the hypothalamic abnormality?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Why do cluster headache, hemicrania continua, paroxysmal hemicrania, and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) have such different phenotypes and treatment responses if the defining abnormality of the trigeminal autonomic cephalalgias is hypothalamic derangement?</p><p></p><p>The hypothalamus is a complex structure with various nuclei and widespread projections to numerous central structures. It is possible that the specific substructures, neurons or biochemical pathways involved in these primary headache syndromes vary, thereby explaining both the different phenotypes and treatment responses.</p><p>Further studies are needed to seek the anatomic or functional basis of these variations. Advances in the pathophysiologic understanding of the trigeminal autonomic cephalalgias are likely to lead to better treatments for these devastatingly painful syndromes.</p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinico-pathophysiologic constructs</strong> – Understanding of the trigeminal autonomic cephalalgias must account for the core clinical features common to the syndromes including the trigeminal distribution pain, the ipsilateral cranial autonomic features, and the cyclical variation of attacks. (See <a class="local">'Pathophysiologic models'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trigeminal autonomic reflex</strong> – Stimulation of trigeminal afferents projecting to nociceptive pathways such as the sphenopalatine ganglion and trigeminal ganglion may result in pain and cranial autonomic symptoms through central disinhibition and neuropeptide release. (See <a class="local">'Trigeminal autonomic reflex'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypothalamic activation </strong>– The most widely accepted theory is that the trigeminal autonomic cephalalgias are due to a functional abnormality in the hypothalamus leading to hypothalamic activation with secondary activation of the trigeminal autonomic reflex, probably via a trigeminal-hypothalamic pathway. (See <a class="local">'Trigeminal autonomic reflex'</a> above and <a class="local">'Hypothalamic activation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular theory</strong> – The vascular theory, largely abandoned, holds that the autonomic symptoms of cluster headache are caused by neurogenic inflammation of the walls of the cavernous sinus. (See <a class="local">'Vascular theory'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997; 120 ( Pt 1):193.</a></li><li><a class="nounderline abstract_t">Wei DY, Goadsby PJ. Cluster headache pathophysiology - insights from current and emerging treatments. Nat Rev Neurol 2021; 17:308.</a></li><li><a class="nounderline abstract_t">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.</a></li><li><a class="nounderline abstract_t">Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002; 1:251.</a></li><li><a class="nounderline abstract_t">Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994; 117 ( Pt 3):427.</a></li><li><a class="nounderline abstract_t">Drummond PD. Mechanisms of autonomic disturbance in the face during and between attacks of cluster headache. Cephalalgia 2006; 26:633.</a></li><li><a class="nounderline abstract_t">Fanciullacci M, Pietrini U, Gatto G, et al. Latent dysautonomic pupillary lateralization in cluster headache. A pupillometric study. Cephalalgia 1982; 2:135.</a></li><li><a class="nounderline abstract_t">Ivanusic JJ, Kwok MM, Ahn AH, Jennings EA. 5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache. Headache 2011; 51:392.</a></li><li><a class="nounderline abstract_t">May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999; 19:115.</a></li><li><a class="nounderline abstract_t">Akerman S, Holland PR, Summ O, et al. A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization. Brain 2012; 135:3664.</a></li><li><a class="nounderline abstract_t">May A, Büchel C, Turner R, Goadsby PJ. Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab 2001; 21:1171.</a></li><li><a class="nounderline abstract_t">Frese A, Evers S, May A. Autonomic activation in experimental trigeminal pain. Cephalalgia 2003; 23:67.</a></li><li><a class="nounderline abstract_t">Schoenen J, Jensen RH, Lantéri-Minet M, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia 2013; 33:816.</a></li><li><a class="nounderline abstract_t">Goadsby PJ, Sahai-Srivastava S, Kezirian EJ, et al. Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial. Lancet Neurol 2019; 18:1081.</a></li><li><a class="nounderline abstract_t">Buture A, Boland JW, Dikomitis L, Ahmed F. Update on the pathophysiology of cluster headache: imaging and neuropeptide studies. J Pain Res 2019; 12:269.</a></li><li><a class="nounderline abstract_t">Chan C, Goadsby PJ. CGRP pathway monoclonal antibodies for cluster headache. Expert Opin Biol Ther 2020; 20:947.</a></li><li><a class="nounderline abstract_t">Goadsby PJ, Dodick DW, Leone M, et al. Trial of Galcanezumab in Prevention of Episodic Cluster Headache. N Engl J Med 2019; 381:132.</a></li><li><a class="nounderline abstract_t">Dodick DW, Goadsby PJ, Lucas C, et al. Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment. Cephalalgia 2020; 40:935.</a></li><li><a class="nounderline abstract_t">May A, Büchel C, Bahra A, et al. Intracranial vessels in trigeminal transmitted pain: A PET study. Neuroimage 1999; 9:453.</a></li><li><a class="nounderline abstract_t">Benoliel R, Sharav Y. Trigeminal neuralgia with lacrimation or SUNCT syndrome? Cephalalgia 1998; 18:85.</a></li><li><a class="nounderline abstract_t">Barbanti P, Fabbrini G, Pesare M, et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002; 22:256.</a></li><li><a class="nounderline abstract_t">Goadsby PJ, Matharu MS, Boes CJ. SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 2001; 21:82.</a></li><li><a class="nounderline abstract_t">Goadsby PJ. Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? J Neurol Neurosurg Psychiatry 2005; 76:301.</a></li><li><a class="nounderline abstract_t">Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain 2002; 125:976.</a></li><li><a class="nounderline abstract_t">Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol 2009; 8:755.</a></li><li><a class="nounderline abstract_t">Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia 1987; 7 Suppl 6:76.</a></li><li><a class="nounderline abstract_t">Strittmatter M, Hamann GF, Grauer M, et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. Neuroreport 1996; 7:1229.</a></li><li><a class="nounderline abstract_t">HORTON BT. Histaminic cephalgia. J Lancet 1952; 72:92.</a></li><li><a class="nounderline abstract_t">KUNKLE EC, PFEIFFER JB Jr, WILHOIT WM, HAMRICK LW Jr. Recurrent brief headache in cluster pattern. Trans Am Neurol Assoc 1952; 56:240.</a></li><li><a class="nounderline abstract_t">Shin YW, Park HJ, Shim JY, et al. Seasonal Variation, Cranial Autonomic Symptoms, and Functional Disability in Migraine: A Questionnaire-Based Study in Tertiary Care. Headache 2015; 55:1112.</a></li><li><a class="nounderline abstract_t">Ekbom K. Nitrolglycerin as a provocative agent in cluster headache. Arch Neurol 1968; 19:487.</a></li><li><a class="nounderline abstract_t">Nelson RF. Testosterone levels in cluster and non-cluster migrainous headache patients. Headache 1978; 18:265.</a></li><li><a class="nounderline abstract_t">Leone M, Patruno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia 1990; 10:235.</a></li><li><a class="nounderline abstract_t">Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50:207.</a></li><li><a class="nounderline abstract_t">Malick A, Burstein R. Cells of origin of the trigeminohypothalamic tract in the rat. J Comp Neurol 1998; 400:125.</a></li><li><a class="nounderline abstract_t">Malick A, Strassman RM, Burstein R. Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J Neurophysiol 2000; 84:2078.</a></li><li><a class="nounderline abstract_t">Wang Q, Mao LM, Han JS. Naloxone-reversible analgesia produced by microstimulation of the arcuate nucleus of the hypothalamus in pentobarbital-anesthetized rats. Exp Brain Res 1990; 80:201.</a></li><li><a class="nounderline abstract_t">Dafny N, Dong WQ, Prieto-Gomez C, et al. Lateral hypothalamus: site involved in pain modulation. Neuroscience 1996; 70:449.</a></li><li><a class="nounderline abstract_t">Lumb BM, Lovick TA. The rostral hypothalamus: an area for the integration of autonomic and sensory responsiveness. J Neurophysiol 1993; 70:1570.</a></li><li><a class="nounderline abstract_t">Benjamin L, Levy MJ, Lasalandra MP, et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study. Neurobiol Dis 2004; 16:500.</a></li><li><a class="nounderline abstract_t">Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004; 109:367.</a></li><li><a class="nounderline abstract_t">Möller M, Mehnert J, May A. Hypothalamic activation discriminates painful and non-painful initiation of the trigeminal autonomic reflex - an fMRI study. Cephalalgia 2020; 40:79.</a></li><li><a class="nounderline abstract_t">May A. Functional anatomy of headache. Neurol Sci 2006; 27 Suppl 2:S103.</a></li><li><a class="nounderline abstract_t">May A. New insights into headache: an update on functional and structural imaging findings. Nat Rev Neurol 2009; 5:199.</a></li><li><a class="nounderline abstract_t">Tso AR, Goadsby PJ. Recent neuroimaging advances in the study of primary headaches. Curr Pain Headache Rep 2015; 19:15.</a></li><li><a class="nounderline abstract_t">May A, Bahra A, Büchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275.</a></li><li><a class="nounderline abstract_t">Sprenger T, Boecker H, Tolle TR, et al. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology 2004; 62:516.</a></li><li><a class="nounderline abstract_t">Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 2006; 59:535.</a></li><li><a class="nounderline abstract_t">Matharu MS, Cohen AS, McGonigle DJ, et al. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 2004; 44:747.</a></li><li><a class="nounderline abstract_t">Sprenger T, Valet M, Platzer S, et al. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 2005; 113:422.</a></li><li><a class="nounderline abstract_t">May A, Bahra A, Büchel C, et al. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 1999; 46:791.</a></li><li><a class="nounderline abstract_t">Cohen AS, Matharu MS, Kalisch R, et al. Functional MRI in SUNCT shows differential hypothalamic activation with increasing pain [abstract]. Cephalalgia 2004; 24:1098.</a></li><li><a class="nounderline abstract_t">Akram H, Miller S, Lagrata S, et al. Optimal deep brain stimulation site and target connectivity for chronic cluster headache. Neurology 2017; 89:2083.</a></li><li><a class="nounderline abstract_t">May A, Kaube H, Büchel C, et al. Experimental cranial pain elicited by capsaicin: a PET study. Pain 1998; 74:61.</a></li><li><a class="nounderline abstract_t">Kupers RC, Svensson P, Jensen TS. Central representation of muscle pain and mechanical hyperesthesia in the orofacial region: a positron emission tomography study. Pain 2004; 108:284.</a></li><li><a class="nounderline abstract_t">Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 2016; 139:1987.</a></li><li><a class="nounderline abstract_t">Schulte LH, Mehnert J, May A. Longitudinal Neuroimaging over 30 Days: Temporal Characteristics of Migraine. Ann Neurol 2020; 87:646.</a></li><li><a class="nounderline abstract_t">Schulte LH, Allers A, May A. Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI. Neurology 2017; 88:2011.</a></li><li><a class="nounderline abstract_t">Schulte LH, Haji AA, May A. Phase dependent hypothalamic activation following trigeminal input in cluster headache. J Headache Pain 2020; 21:30.</a></li><li><a class="nounderline abstract_t">Yang FC, Chou KH, Fuh JL, et al. Altered hypothalamic functional connectivity in cluster headache: a longitudinal resting-state functional MRI study. J Neurol Neurosurg Psychiatry 2015; 86:437.</a></li><li><a class="nounderline abstract_t">Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1:658.</a></li><li><a class="nounderline abstract_t">Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet 2001; 357:1016.</a></li><li><a class="nounderline abstract_t">Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol 2005; 62:1270.</a></li><li><a class="nounderline abstract_t">Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004; 127:220.</a></li><li><a class="nounderline abstract_t">Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005; 128:932.</a></li><li><a class="nounderline abstract_t">Denuelle M, Fabre N, Payoux P, et al. Hypothalamic activation in spontaneous migraine attacks. Headache 2007; 47:1418.</a></li><li><a class="nounderline abstract_t">Maniyar FH, Sprenger T, Monteith T, et al. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014; 137:232.</a></li><li><a class="nounderline abstract_t">Hardebo JE. Activation of pain fibers to the internal carotid artery intracranially may cause the pain and local signs of reduced sympathetic and enhanced parasympathetic activity in cluster headache. Headache 1991; 31:314.</a></li></ol></div><div id="topicVersionRevision">Topic 3339 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9055807" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33782592" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cluster headache pathophysiology - insights from current and emerging treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12849458" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pathophysiology of cluster headache: a trigeminal autonomic cephalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7518321" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16686902" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Mechanisms of autonomic disturbance in the face during and between attacks of cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6897524" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Latent dysautonomic pupillary lateralization in cluster headache. A pupillometric study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21352213" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : 5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10027765" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23065481" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11598494" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12534584" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Autonomic activation in experimental trigeminal pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23314784" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31701891" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30655693" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Update on the pathophysiology of cluster headache: imaging and neuropeptide studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32241175" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : CGRP pathway monoclonal antibodies for cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31291515" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Trial of Galcanezumab in Prevention of Episodic Cluster Headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32050782" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10329285" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intracranial vessels in trigeminal transmitted pain: A PET study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9533603" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Trigeminal neuralgia with lacrimation or SUNCT syndrome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12100086" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Unilateral cranial autonomic symptoms in migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11422087" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : SUNCT syndrome or trigeminal neuralgia with lacrimation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15716514" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11960888" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Persistence of attacks of cluster headache after trigeminal nerve root section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19608101" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pathophysiology of trigeminal autonomic cephalalgias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3442810" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The cyclic relationship of natural illumination to cluster period frequency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8817538" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14908316" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Histaminic cephalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13038844" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Recurrent brief headache in cluster pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26198478" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Seasonal Variation, Cranial Autonomic Symptoms, and Functional Disability in Migraine: A Questionnaire-Based Study in Tertiary Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4971733" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nitrolglycerin as a provocative agent in cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/721458" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Testosterone levels in cluster and non-cluster migrainous headache patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2272093" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Neuroendocrine dysfunction in cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3572435" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9762871" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cells of origin of the trigeminohypothalamic tract in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11024099" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2358028" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Naloxone-reversible analgesia produced by microstimulation of the arcuate nucleus of the hypothalamus in pentobarbital-anesthetized rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8848153" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Lateral hypothalamus: site involved in pain modulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8283214" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The rostral hypothalamus: an area for the integration of autonomic and sensory responsiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15262261" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15157698" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31382763" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hypothalamic activation discriminates painful and non-painful initiation of the trigeminal autonomic reflex - an fMRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16688610" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Functional anatomy of headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19347025" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : New insights into headache: an update on functional and structural imaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26017707" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Recent neuroimaging advances in the study of primary headaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9690407" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hypothalamic activation in cluster headache attacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14872051" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Specific hypothalamic activation during a spontaneous cluster headache attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16489610" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Posterior hypothalamic activation in paroxysmal hemicrania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15330820" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Posterior hypothalamic and brainstem activation in hemicrania continua.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15661452" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10554000" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Functional MRI in SUNCT shows differential hypothalamic activation with increasing pain [abstract]</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29030455" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Optimal deep brain stimulation site and target connectivity for chronic cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9514561" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Experimental cranial pain elicited by capsaicin: a PET study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15030948" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Central representation of muscle pain and mechanical hyperesthesia in the orofacial region: a positron emission tomography study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27190019" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32031707" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Longitudinal Neuroimaging over 30 Days: Temporal Characteristics of Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28446645" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32228453" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Phase dependent hypothalamic activation following trigeminal input in cluster headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24983632" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Altered hypothalamic functional connectivity in cluster headache: a longitudinal resting-state functional MRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7585147" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Brain stem activation in spontaneous human migraine attacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11293599" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Brainstem activation specific to migraine headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16087768" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A positron emission tomographic study in spontaneous migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14607792" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15705611" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18052951" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Hypothalamic activation in spontaneous migraine attacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24277718" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1860790" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Activation of pain fibers to the internal carotid artery intracranially may cause the pain and local signs of reduced sympathetic and enhanced parasympathetic activity in cluster headache.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
